Actinium Pharmaceuticals Inc
ATNM·Stocks·Pharmaceuticals Major·United States·NYSE·USD
Price
$1.18
Today
-1.7%
YTD
-12.5%
About
Founded in 2000, Actinium Pharmaceuticals is a clinical-stage biopharmaceutical company. It develops and commercialises therapies for adoptive cell or bone marrow transplant therapies. It operates within the US and has headquarters in New York. Actinium Pharmaceuticals is listed on the NYSE American with the ticker ATNM. Educate yourself about ATNM stock by adding it to your eToro watchlist.
Price chart
Closing price history for ATNM (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-1.24
P/S (TTM)322.79
P/B (TTM)12.67
Market cap$29.18M
Cap tierMicro-cap
Industry avg P/E-43.26
Profitability
Gross margin-828.89%
EBIT margin-28346.67%
Net margin-5701.11%
ROE-167.66%
ROA-41.15%
Earnings & Revenue
Revenue (TTM)$90,000.00
Revenue growth (1Y)+11.1%
EPS (TTM)-$0.75
Free cash flow$-22.98M
Total debt$1.52M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.96
Employees25
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.